TransMedics Group, Inc. Financing Cash Flow
TransMedics Group, Inc. (TMDX) reported Financing Cash Flow of $4.73 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-04
- TransMedics Group, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $970.00K, a 86.32% decline year-over-year.
- TransMedics Group, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $3.76M, a 24.24% increase year-over-year.
- TransMedics Group, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $3.10M, a 161.30% increase year-over-year.
- TransMedics Group, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $3.64M, a 53.69% decline year-over-year.
- TransMedics Group, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $16.86M, a 26.30% decline from fiscal 2024.
- TransMedics Group, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $22.87M, a 94.29% decline from fiscal 2023.
- TransMedics Group, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $400.42M, a 138.45% increase from fiscal 2022.
- TransMedics Group, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $167.93M, a 11955.06% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $970.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $4.73M 10-Q · filed 2026-08-04 | $7.83M derived: sum of 3 quarters · filed 2026-08-04 | $11.47M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $3.76M 10-Q · filed 2026-05-05 | $6.86M derived: sum of 2 quarters · filed 2026-05-05 | $10.50M derived: sum of 3 quarters · filed 2026-05-05 | $17.59M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $6.74M derived: sum of 2 quarters · filed 2026-02-24 | $13.83M derived: sum of 3 quarters · filed 2026-08-04 | $16.86M 10-K · filed 2026-02-24 |
| 2025-09-30 | $3.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $10.73M derived: sum of 2 quarters · filed 2026-08-04 | $13.76M 10-Q · filed 2025-10-29 | $14.94M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $7.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $10.12M 10-Q · filed 2026-08-04 | $11.30M derived: sum of 3 quarters · filed 2026-08-04 | $19.16M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $3.03M 10-Q · filed 2026-05-05 | $4.21M derived: sum of 2 quarters · filed 2026-05-05 | $12.08M derived: sum of 3 quarters · filed 2026-05-05 | $22.72M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $9.05M derived: sum of 2 quarters · filed 2026-02-24 | $19.69M derived: sum of 3 quarters · filed 2026-02-24 | $22.87M 10-K · filed 2026-02-24 |
| 2024-09-30 | $7.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $18.50M derived: sum of 2 quarters · filed 2025-10-29 | $21.69M 10-Q · filed 2025-10-29 | $22.61M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $10.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $13.83M 10-Q · filed 2025-07-30 | $14.75M derived: sum of 3 quarters · filed 2026-02-24 | $16.27M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $3.19M 10-Q · filed 2025-05-08 | $4.11M derived: sum of 2 quarters · filed 2026-02-24 | $5.63M derived: sum of 3 quarters · filed 2026-02-24 | $399.64M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $924.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.45M derived: sum of 2 quarters · filed 2026-02-24 | $396.46M derived: sum of 3 quarters · filed 2026-02-24 | $400.42M 10-K · filed 2026-02-24 |
| 2023-09-30 | $1.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $395.54M derived: sum of 2 quarters · filed 2024-10-29 | $399.49M 10-Q · filed 2024-10-29 | $402.56M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $394.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $397.97M 10-Q · filed 2024-08-01 | $401.04M derived: sum of 3 quarters · filed 2025-02-27 | $565.26M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $3.96M 10-Q · filed 2024-05-02 | $7.02M derived: sum of 2 quarters · filed 2025-02-27 | $171.24M derived: sum of 3 quarters · filed 2025-02-27 | $171.48M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $3.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $167.28M derived: sum of 2 quarters · filed 2025-02-27 | $167.52M derived: sum of 3 quarters · filed 2025-02-27 | $167.93M 10-K · filed 2025-02-27 |
| 2022-09-30 | $164.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $164.46M derived: sum of 2 quarters · filed 2023-11-08 | $164.86M 10-Q · filed 2023-11-08 | $164.91M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $237.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $642.00K 10-Q · filed 2023-08-04 | $687.00K derived: sum of 3 quarters · filed 2024-02-27 | $1.24M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $405.00K 10-Q · filed 2023-05-04 | $450.00K derived: sum of 2 quarters · filed 2024-02-27 | $1.00M derived: sum of 3 quarters · filed 2024-02-27 | $1.22M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $597.00K derived: sum of 2 quarters · filed 2024-02-27 | $810.00K derived: sum of 3 quarters · filed 2024-02-27 | $1.39M 10-K · filed 2024-02-27 |
| 2021-09-30 | $552.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $765.00K derived: sum of 2 quarters · filed 2022-11-04 | $1.35M 10-Q · filed 2022-11-04 | $1.38M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $213.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $796.00K 10-Q · filed 2022-08-03 | $829.00K derived: sum of 3 quarters · filed 2023-02-27 | $650.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $583.00K 10-Q · filed 2022-05-05 | $616.00K derived: sum of 2 quarters · filed 2023-02-27 | $437.00K derived: sum of 3 quarters · filed 2023-02-27 | $75.98M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$146.00K derived: sum of 2 quarters · filed 2023-02-27 | $75.40M derived: sum of 3 quarters · filed 2023-02-27 | $75.55M 10-K · filed 2023-02-27 |
| 2020-09-30 | -$179.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $75.36M derived: sum of 2 quarters · filed 2021-11-09 | $75.52M 10-Q · filed 2021-11-09 | $75.27M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $75.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $75.69M 10-Q · filed 2021-08-06 | $75.45M derived: sum of 3 quarters · filed 2021-05-07 | $73.02M derived: sum of 4 quarters · filed 2021-05-07 |
| 2020-03-31 | $152.00K 10-Q · filed 2021-05-07 | -$94.00K derived: sum of 2 quarters · filed 2021-05-07 | -$2.52M derived: sum of 3 quarters · filed 2021-05-07 | $93.57M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-28 | -$246.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$2.67M derived: sum of 2 quarters · filed 2021-03-11 | $93.42M derived: sum of 3 quarters · filed 2021-03-11 | $92.72M 10-K · filed 2021-03-11 |
| 2019-09-28 | -$2.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $93.67M derived: sum of 2 quarters · filed 2020-08-07 | $92.97M 10-Q · filed 2019-11-08 | |
| 2019-06-29 | $96.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $95.40M 10-Q · filed 2020-08-07 | ||
| 2019-03-30 | -$697.00K 10-Q · filed 2020-05-06 | |||
| 2018-12-29 | $22.06M 10-K · filed 2020-03-17 | |||
| 2018-09-29 | $24.34M 10-Q · filed 2019-11-08 | |||
| 2018-06-30 | $25.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $24.38M 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | -$880.00K 10-Q · filed 2019-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |